Quality, innovation, and excellence: these are the outstanding values that set CryoCord apart from others. Established in 2002, this award-winning premier stem cell banking company was created on the talents, skills, experience and vision of a dedicated group of visionary medical and investment professionals, who envisioned the establishment of a stem cell cryopreservation bank in Malaysia. CryoCord has since grown both in strength and size, establishing a prominent presence in Southeast Asia. Today, CryoCord has earned the trust of tens of thousands of families who turn to CryoCord’s unparalleled expertise for the highest standards of stem cell storage.

CryoCord is laboratory-certified with cGMP (PIC/S) requisites awarded by the National Pharmaceutical Regulatory Agency, a division of the Ministry of Health, Malaysia, and holds an Association for the Advancement of Blood & Biotherapies accreditation, an international mark of excellence that demonstrates a facility’s commitment to quality and safety. In addition, the company is renowned for having the largest laboratory with 10 Class-100 cleanrooms that maintain stringent safety and hygiene standards for handling precious stem cells.

Back in 2009, CryoCord was the first company in Southeast Asia to introduce mesenchymal stem cells (CordMSCs) storage. Moving forward, CryoCord is now offering immune cells (IMUENCEL) storage and induced pluripotent stem cell (CordPSCs-i) storage to provide consumers with even more possibilities for securing a future of health and healing.